MedPath

Acceptance and Efficacy of Live Supervision

Not Applicable
Completed
Conditions
Mental Disorders
Interventions
Behavioral: Computer-assisted live supervision
Behavioral: Delayed video-based supervision
Registration Number
NCT01510080
Lead Sponsor
Goethe University
Brief Summary

In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. This study compares computer-assisted live supervision and delayed video-based supervision regarding efficacy and acceptance among therapists, patients and supervisors. The efficacy of supervision is defined on different levels such as change of psychotherapeutic competence, nondisclosure, self-efficacy, self-awareness of the supervisee as well as therapeutic alliance, supervisory alliance and therapy outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Having successfully completed the interim audit
  • Having started to treat ambulant patients under supervision
Exclusion Criteria

Patients

Inclusion Criteria:

  • Meeting ICD 10 criteria for a mental disorder
  • Informed consent

Exclusion Criteria:

  • Currently in psychotherapy
  • Suicidal tendency
  • Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Computer-assisted live supervisionComputer-assisted live supervisionSupervisees assigned to this group will receive 8 sessions of computer-assisted live supervision and 4 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. Computer-assisted live supervision is also known as "bug-in-the-eye" (BITE) supervision. The supervisor observes the therapy session with the help of a webcam and types messages on his computer. The instructions to the supervisee appear on a second monitor located in the therapy room where the supervisee can view it whenever he wants to.
Delayed video-based supervisionDelayed video-based supervisionSupervisees assigned to this group will receive 12 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. During delayed video-based supervision the supervisor and the supervisee spend 50 minutes reviewing selected parts of video recorded therapy sessions and discussing the case.
Primary Outcome Measures
NameTimeMethod
Supervisory Questionnaire (SQ)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses nondisclosure of the supervisee during supervision

Supervisee Levels Questionnaire (SLQ-R)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses self awareness, motivation and dependency- autonomy of supervisees

Counseling Self-Estimate Inventory (COSE)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses self efficacy of the supervisee

Fragebogen zur Psychotherapie-Supervision Kurzform (FSPT-K)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses level of development and supervision needs of the therapist

Secondary Outcome Measures
NameTimeMethod
Helping Alliance Questionnaire (HAQ)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses the therapeutic alliance

Supervisory Working Alliance Inventory (SWAI)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses the supervisory relationship

Beck-Depression Inventory II (BDI-II)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses depressive symptoms

Beck Anxiety Inventory II (BAI)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that asessses anxiety symptoms

Brief Symptom Inventory (BSI)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses aspects of general psychopathology

Health-related quality of life (SF-12)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses the health-related quality of life

Client Satisfaction Questionnaire (CSQ8)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses satisfaction with therapy

Stundenbogen zur Supervisionsbeurteilung (STEP SV)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

self-report measure that assesses satisfaction with supervision

Cognitive Therapy Scale (CTS)participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

clinician-rated measure that assesses psychotherapeutic competencies

Trial Locations

Locations (1)

Department of Clinical Psychology and Psychotherapy of the Wolfgang Goethe University

🇩🇪

Frankfurt, Hessen, Germany

© Copyright 2025. All Rights Reserved by MedPath